CLINICAL_TRIALS
trial_result
· 2014-08-06
Clinical Trial Update: Pharmacodynamics and Pharmacokinetics of Empagliflozin and Torasemide in Patients With Type 2 Diabetes [Phase 1]
Summary
Phase 1 pharmacodynamics and pharmacokinetics study of empagliflozin and torasemide in patients with Type 2 diabetes; results posted in 2014.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Boehringer Ingelheim | Conditions: Diabetes Mellitus, Type 2 | Phase 1 | Status: COMPLETED | Results posted: 2014-08-06